Weight Loss Plateau with GLP-1 Agonists
Thanks for listening to The Peptide Podcast.
In the journey of weight loss, everyone eventually reaches a plateau, even when using newer GLP-1 receptor agonists like semaglutide (Wegovy) and tirzepatide (Zepbound). This phase is where the body finds a new set point and weight. During this plateau, some individuals may experience a gradual increase in appetite or "food noise", while others can maintain their current state. Other metabolic markers like blood pressure and A1c, stabilize or only fluctuate slightly.
Read the Full Episode Transcript…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.